Table 3. Hickman line and pump device complications by treatment arms.
| Gastrazole (n=9) | Placebo (n=9) | |
|---|---|---|
| Trial A | ||
| Infection (%) | 56 | 22 |
| Haematoma (%) | 11 | 22 |
| Device breakage (%) | 33 | 22 |
| Device leakage (%) | 33 | 22 |
| Device failure NOS (%) | 78 | 33 |
| Gastrazole (n=53) | 5-FU (n=42) | |
|---|---|---|
| Trial B | ||
| Infection (%) | 21 | 19 |
| Thrombosis (%) | 6 | 0 |
| Pneumothorax (%) | 4 | 2 |
| Blocked line (%) | 25 | 2 |
| Damaged line (%) | 2 | 2 |
| Any complications (%) | 55 | 36 |
NOS=not otherwise specified; 5-FU=5-fluorouracil.
Category coding for Hickman line and pump device complications was different between trials A and B.